Identification of glucocorticoid receptor domains necessary for transcriptional activation of the mouse mammary tumor virus promoter integrated in the genome.
It has previously been determined that the mouse mammary tumor virus (MMTV) promoter when integrated in the genome assumes a defined chromatin structure which is disrupted upon addition of glucocorticoids. In contrast, a transiently introduced MMTV promoter has a random nucleoprotein structure. To reveal glucocorticoid receptor (GR) domains necessary for transcriptional activation of the MMTV promoter we compared the effects of mutations of the GR on transcriptional activation of the stably integrated versus transiently introduced MMTV promoter. For this purpose we generated a GR-negative cell line which has an MMTV promoter/reporter construct integrated in the genome and studied the transcriptional activation of this construct by different GR mutants introduced into the cells. Transcriptional activation of the integrated and transiently introduced promoter was achieved by the wild-type GR or a chimeric receptor in which the MR hormone-binding domain (HBD) replaced the GR HBD. In contrast, we found that deletion of the HBD of the GR or replacement of this region with the equivalent domain of the estrogen receptor produced receptors that were unable to activate the MMTV promoter integrated in the genome although these receptors efficiently activated the transiently introduced MMTV promoter. The HBD was not the sole determinant of MMTV transcriptional activation when integrated in the genome. Chimeric receptors which harbored the MR amino terminal domain or the wild-type MR were also unable to activate the integrated MMTV promoter. Taken together, these data indicate a rigid requirement for sequences in both the GR amino and the carboxy terminal domains for transcriptional activation of a hormone response element in the defined chromatin context of the MMTV promoter.
Bonovich
M T
MT
Department of Biochemistry and Molecular Biology, Georgetown University, Washington, DC 20007, USA.
List
H J
HJ
Zhang
S
S
Danielsen
M
M
Riegel
A T
AT
D000450:Aldosterone / Q000494:pharmacology; D000818:Animals; D001665:Binding Sites; D003907:Dexamethasone / Q000494:pharmacology; D004958:Estradiol / Q000494:pharmacology; D005786:Gene Expression Regulation / Q000187:drug effects; D017930:Genes, Reporter; D018189:Immunomagnetic Separation; D007739:L Cells; D008156:Luciferases / Q000096:biosynthesis / Q000235:genetics; D008324:Mammary Tumor Virus, Mouse / Q000235:genetics* / Q000502:physiology; D051379:Mice; D011401:Promoter Regions, Genetic; D011533:Proviruses / Q000235:genetics* / Q000502:physiology; D051381:Rats; D011965:Receptors, Glucocorticoid / Q000737:chemistry* / Q000187:drug effects / Q000502:physiology; D011993:Recombinant Fusion Proteins / Q000187:drug effects; D017384:Sequence Deletion; D013329:Structure-Activity Relationship; D014158:Transcription, Genetic / Q000187:drug effects; D014162:Transfection; D014775:Virus Activation / Q000187:drug effects; D016662:Virus Integration
D011965:Receptors, Glucocorticoid; D011993:Recombinant Fusion Proteins; D000450:Aldosterone; D004958:Estradiol; D003907:Dexamethasone; D008156:Luciferases